Edit

H.I.G. BioHealth Partners

https://higbio.com/

Last activity: 02.03.2022

Active

Categories: HealthTech

BioVentures’s competitors.

Mentions

Location: United States, Florida, Miami

Employees: 11-50

Founded date: 1993

Investors 1

Date	Name	Website
-	Renaissanc...	renvcf.com

Mentions in press and media 19

Date	Title	Description
02.03.2022	H.I.G. Capital Expands BioHealth Team with Addition of Gwen Watanabe	STAMFORD – March 2, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated life-scie...
26.10.2021	H.I.G. BioHealth Partners Co-Leads a $52M Financing for Click Therapeutics	STAMFORD, CT – October 26, 2021 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global alternative investment firm with over $45 billion of equity capital under management,*...
15.02.2019	Axovant spin-off launched in Basel with an initial funding of over CHF100m
14.03.2018	H.I.G. Joins Funding Round for On Target Labs	On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, has secured an additional financing as part of its Series B capital raise which initially clo...
14.03.2018	On Target Laboratories Raises Additional Capital from H.I.G. BioHealth Partners, Elevate Ventures and Helsinn	WEST LAFAYETTE, Ind. 14 March 2018 â€“ On Target Laboratories, Inc., a privately-held biotechnology company that is developing tumour-targeted fluorescent dyes to improve cancer surgery, has secured additional financing as part of its Serie...
14.05.2015	Intact Vascular Raises $38.9M in Series B VC Financing	Intact Vascular, Inc., a Wayne, Pa.-based developer of medical devices for minimally invasive peripheral vascular procedures, raised $38.9m in Series B venture capital financing. The round was led by New Enterprise Associates (NEA), with pa...
16.04.2014	ForSight VISION5 Sees $15M Series C Funding	MENLO PARK, CA, ForSight VISION5 has completed its Series C financing which raised $15 million and was led by H.I.G. BioVentures. >> Click here for more funding data on ForSight VISION5 >> To export ForSight VISION5 funding ...
16.04.2014	ForSight VISION5 Completes $15M Series C Financing	ForSight VISION5, a Menlo Park, CA-based developer of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy, completed a $15m Series C finan...
16.04.2014	Iconic Therapeutics Completes $20M Series B-1 Equity Financing	Iconic Therapeutics, Inc., a Atlanta, GA and South San Francisco, CA-based biotechnology company focused on developing therapeutics for serious eye disorders, completed a $20m Series B-1 equity financing. Backers included new investors MPM ...
23.12.2013	Medical device maker nets $4.7M to tackle peripheral artery disease complications	The Wayne, Pa.-based company has raised about $4.7 million from five investors, according to a document filed with the Securities and Exchange Commission. Among its investors are Quaker Partners and H.I.G. BioVentures, as well as angel inve...
08.05.2013	Three examples of how “the system” is changing medtech investment decisions	Neilsen’s comment was one of two that showed how governments, C-suite executives and payers are guiding investment decisions in the medtech world. Josh Baltzell of Split Rock Partners said that one of his portfolio companies is selling into...
05.09.2012	NeuWave Medical Secures $14M Series B	MADISON, WI, Medical device company, NeuWave Medical, announced today that it has raised a $14 million Series B financing, led by new investor H.I.G. BioVentures. >> Click here for more funding data on NeuWave Medical >> To ...
05.09.2012	Intact Vascular Announces $15.5 MM Series A	WAYNE, PA, Developer of medical devices for minimally invasive peripheral vascular procedures, today announced the completion of a $15.5 MM Series A financing. >> Click here for more funding data on Intact Vascular >> To exp...
05.09.2012	NeuWave Medical Raises $14M in Series B Financing	NeuWave Medical, a Madison, WI-based medical device company, has raised a $14m in Series B financing. The round was led by new investor H.I.G. BioVentures, with participation from existing shareholders Venture Investors, WARF and the State ...
05.09.2012	Intact Vascular Closes $15.5M Series A Financing	Intact Vascular, Inc., a Wayne, PA-based developer of medical devices for minimally invasive peripheral vascular procedures, has closed a $15.5m Series A financing. The round was co-led by Quaker Partners, H.I.G. BioVentures, with participa...
10.04.2012	H.I.G. Capital Closes Life Sciences Fund at $268M	Global private investment firm H.I.G. Capital, LLC has held the final close of its H.I.G. BioVentures II at $268m. H.I.G. BioVentures II, L.P., which exceeded its $250m target, was raised from public and private pension funds, foundations, ...
10.04.2012	H.I.G. BioVentures Closes $268M Fund	MIAMI, FL, The fund held its final closing on March 28, 2012, and was over-subscribed with total aggregate commitments of $268 million. >> Click here for more funding data on H.I.G. BioVentures >> To export H.I.G. BioVenture...
-	Medical device maker nets $4.7M to tackle peripheral artery disease complications	Medical device company Intact Vascular, which is developing tools to help the 8 million people with peripheral artery disease, has raised fresh capital. It has also started enrollment for a multi-center study to gather data supporting the s...
-	Three examples of how “the system” is changing medtech investment decisions	Will Kaiser pay for this? Kirk Nielsen of Versant Ventures said that has become the litmus test for healthcare investing in the new world of healthcare reform. An “early stage vs. late stage” panel at today’s MedTech Investing conference in...

H.I.G. BioHealth Partners

Investors 1

Mentions in press and media 19

Reviews 0